NCT06650566 - Study of LM-299 in Subjects Advanced Malignant Tumors | Biotech Hunter

Enrollment

108

Participants

Timeline

Start Date

October 9, 2024

Primary Completion Date

December 31, 2026

Study Completion Date

July 31, 2027

Conditions

Malignant Tumors

Interventions

DRUG

LM-299

Q2W/Q3W,Intravenous Drip

Trial Locations (6)

NOT_YET_RECRUITING

One Clinical Research, Perth

NOT_YET_RECRUITING

the first affiliated hospital of Xinxiang medical University, Xinxiang

NOT_YET_RECRUITING

Liaocheng people's hospital, Liaocheng

NOT_YET_RECRUITING

Zibo municipal hospital, Zibo

NOT_YET_RECRUITING

Shanghai Dongfang Hospital (Tongji University Affiliated Dongfang Hospital), Shanghai

RECRUITING

Shanghai GoBroad Cancer Hospital China Pharmaceutical University, Shanghai